<code id='F077CE8751'></code><style id='F077CE8751'></style>
    • <acronym id='F077CE8751'></acronym>
      <center id='F077CE8751'><center id='F077CE8751'><tfoot id='F077CE8751'></tfoot></center><abbr id='F077CE8751'><dir id='F077CE8751'><tfoot id='F077CE8751'></tfoot><noframes id='F077CE8751'>

    • <optgroup id='F077CE8751'><strike id='F077CE8751'><sup id='F077CE8751'></sup></strike><code id='F077CE8751'></code></optgroup>
        1. <b id='F077CE8751'><label id='F077CE8751'><select id='F077CE8751'><dt id='F077CE8751'><span id='F077CE8751'></span></dt></select></label></b><u id='F077CE8751'></u>
          <i id='F077CE8751'><strike id='F077CE8751'><tt id='F077CE8751'><pre id='F077CE8751'></pre></tt></strike></i>

          hotspot

          hotspot

          author:comprehensive    Page View:648
          After a drawn-out lobbying fight, ARPA-H chose its headquarters: a hub and spokes model, with three central locations in Boston, Texas, and D.C. David L. Ryan/Boston Globe

          WASHINGTON — Cities and states have been clamoring to play host to the Advanced Research Projects Agency for Health since before the agency existed — before, in fact, anyone truly knew what ARPA-H was.

          But the lobbying campaign from universities, business leaders, members of Congress, and big-city mayors is finally over.

          advertisement

          The end came not with a dramatic reveal or a formal ribbon-cutting, but with a largely bureaucratic and anticlimactic announcement that the Biden administration plans to share the wealth. ARPA-H will be housed in a hub-and-spoke model across three major metro areas: The D.C. suburbs; Cambridge, Mass.; and Dallas. Additional “spokes,” the agency announced Tuesday, will be spread across the country at 10 sites spanning from Florida to Alaska.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          Readout Newsletter: Parkinson's study, Gilead, CG Oncology
          Readout Newsletter: Parkinson's study, Gilead, CG Oncology

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Medicare bonuses could stop drug shortages under Senate plan

          Sen.RonWyden(D-Ore.),chairmanoftheSenateFinanceCommitteeMariamZuhaib/APWASHINGTON—AkeySenatecommitte